The FDA approved the Wegovy pill in December 2025, the first once-daily oral GLP-1 approved for weight loss in adults, launching in the US in January 2026
Oxidative and nitrative protein modifications in Parkinsons disease
ISO 17034:2016: General requirements for the competence of reference material producers. ISO
Antioxidants 10 (1), 92 (2021)
District Court for the District of Massachusetts granted summary judgment in favor of GlaxoSmithKline based on federal preemption i.e., that plaintiffs claims about GSKs labels, which were based on state law, were preempted by federal law, under which the FDA would not have allowed the types of label modifications plaintiffs argued GSK should have made
Research vials most commonly ship in 5 mg, 10 mg, and 20 mg strengths, and you can browse documented per-vial references in our dosage protocol catalog